Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medison Pharma Canada is a leading commercial partner for global biotech companies, specializing in the commercialization of highly innovative specialty medicines in the Canadian market. As a subsidiary of the Israel-based Medison Pharma, the company provides a full-stack solution for market access, medical affairs, and commercial operations. They bridge the gap between international biotech developers and local patients, particularly in the fields of oncology, rare diseases, and immunology. Their portfolio includes partnerships with major players such as BioMarin Pharmaceutical, Deciphera Pharmaceuticals, and Ipsen. By acting as a local proxy for international manufacturers, Medison ensures Canadian patients gain access to transformative therapies for high-unmet-need conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medison Pharma Canada.